We are live on ! Find out more
AZN icon

AstraZeneca
AZN

401 hedge funds and large institutions have $5.76B invested in AstraZeneca in 2014 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 126 increasing their positions, 145 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more call options, than puts

Call options by funds: $1.12B | Put options by funds: $702M

1.52% less ownership

Funds ownership: 7.91% → 6.39% (-1.5%)

4% less funds holding

Funds holding: 418 → 401 (-17)

13% less repeat investments, than reductions

Existing positions increased: 126 | Existing positions reduced: 145

23% less capital invested

Capital invested by funds: $7.43B → $5.76B (-$1.67B)

23% less first-time investments, than exits

New positions opened: 40 | Existing positions closed: 52

33% less funds holding in top 10

Funds holding in top 10: 12 → 8 (-4)

Holders
401
Holders Change
-17
Holders Change %
-4.07%
% of All Funds
11.63%
Holding in Top 10
8
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-33.33%
% of All Funds
0.23%
New
40
Increased
126
Reduced
145
Closed
52
Calls
$1.12B
Puts
$702M
Net Calls
+$419M
Net Calls Change
+$58.1M

Top Buyers

Rank Fund Capital Flow
1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$88.4M
2
Deutsche Bank
Deutsche Bank
Germany
+$49.4M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$43.4M
4
BIM
BlackRock Investment Management
Delaware
+$32.6M
5
PI
Putnam Investments
Massachusetts
+$31.7M

Top Sellers

Rank Fund Capital Flow
1
MCM
Mason Capital Management
New York
-$249M
2
Franklin Resources
Franklin Resources
California
-$239M
3
Jane Street
Jane Street
New York
-$127M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$123M
5
OCAM
Owl Creek Asset Management
New York
-$111M
Name Holding Trade Value Shares
Change 		Change in
Stake
LM
126
Lincluden Management
Ontario, Canada
$3.43M – – –
Janney Montgomery Scott
127
Janney Montgomery Scott
Pennsylvania
$3.41M +$98.7K +1,349 +3%
CS
128
Credit Suisse
Switzerland
$3.39M -$50.5M -689,787 -94%
EIM
129
Emerson Investment Management
Massachusetts
$3.37M +$9.15K +125 +0.3%
TAL
130
TIG Advisors LLC
New York
$3.32M +$3.41M +46,526 New
TA
131
Teachers Advisors
New York
$3.28M +$1.43M +19,600 +75%
Natixis Advisors
132
Natixis Advisors
Massachusetts
$3.28M -$837K -11,430 -20%
CA
133
Commerzbank Aktiengesellschaft
Germany
$3.25M -$427K -5,834 -11%
OA
134
Oak Associates
Ohio
$3.05M – – –
CIC
135
Crawford Investment Counsel
Georgia
$3.04M +$1.38M +18,900 +80%
Lord, Abbett & Co
136
Lord, Abbett & Co
New Jersey
$3.03M +$3.1M +42,378 New
GI
137
GAMCO Investors
Connecticut
$2.99M +$110K +1,500 +4%
KeyBank National Association
138
KeyBank National Association
Ohio
$2.97M -$69.7K -952 -2%
Commonwealth Equity Services
139
Commonwealth Equity Services
Massachusetts
$2.85M +$114K +1,553 +4%
CA
140
Continental Advisors
Utah
$2.71M – – –
LMGAM
141
Liberty Mutual Group Asset Management
Massachusetts
$2.66M +$2.73M +37,234 New
MCA
142
Metropolitan Capital Advisors
New York
$2.63M +$2.7M +36,870 New
WMSA
143
Weiss Multi-Strategy Advisers
New York
$2.5M +$366K +5,000 +17%
FBT
144
First Bankers Trust
Kentucky
$2.5M +$7.32K +100 +0.3%
COPPSERS
145
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$2.33M +$2.38M +32,552 New
IGIM
146
I.G. Investment Management
Manitoba, Canada
$2.32M +$412K +5,628 +21%
GCIA
147
Gabelli & Co Investment Advisers
New York
$2.29M – – –
RCM
148
Riverhead Capital Management
Delaware
$2.26M – – –
AIG
149
American International Group
New York
$2.22M -$122K -1,667 -5%
Truist Financial
150
Truist Financial
North Carolina
$2.22M -$2.14M -29,236 -49%
4 5
6
7 8

AZN Hedge Fund Activity: Q3 2014 in Review

401 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q3 2014, worth a combined $5.76B — down 23% from $7.43B a quarter earlier.

Sellers outnumbered buyers: 52 funds closed out of AZN and 40 opened new positions — a net loss of 12 holders — while 145 trimmed existing stakes and 126 added.

The largest buyer was Arrowstreet Capital, adding an estimated $88.4M. The largest seller was Mason Capital Management, exiting entirely with an estimated $249M sold.

  • 401 institutional investors held AstraZeneca (AZN) as of Q3 2014, down from 418 in Q2 2014.
  • Funds reported $5.76B of AstraZeneca stock for Q3 2014, down 23% quarter-over-quarter.
  • 40 funds opened new AstraZeneca positions in Q3 2014 and 52 closed out, a net change of -12 holders.
  • The largest AstraZeneca buyer in Q3 2014 was Arrowstreet Capital, an estimated $88.4M added.
  • The largest AstraZeneca seller in Q3 2014 was Mason Capital Management, an estimated $249M sold.

Based on aggregated 13F filings for Q3 2014.